Remind you the announcement of previous month where Biden says: “I can announce that the manufacturers of ten drugs are coming to the negotiating table to lower prices. They’re taking steps to participate in the negotiating program so we can give seniors the best possible deal.”
In total, the 10 drugs selected for negotiation accounted for $3.4 billion in out-of-pocket costs for an estimated 9 million Medicare enrolees in 2022. These drugs are used to treat heart failure, diabetes, arthritis, cancers, blood clots, and other conditions.
XALERTO 
Prevents/treats: Blood clots, coronary or peripheral artery disease
Around 1.3 million people on Meidcare Annually Rely on Xarelto… 
Seniors spend over $ 591 million out-of-pocket on Xarelto in 2022
Avarage out-of-pocket cost for Xarelto in 2022 was $617 …

While Big pharma makes record profits.
Xarelto’s sellers executed over $54 billion in stock buypacks since the drug launched
Xarelto’s sellers spent over $175 million on lobbying since the drug launched
Big Pharma spent nearly $ 400 million on lobbying in 2022 alone 

Announced White House Administration today